{
  "id": "5e6e9a2fc6a8763d23000007",
  "type": "factoid",
  "question": "What disease is associated with Anticitrullinated peptide antibodies (ACPAs)?",
  "ideal_answer": "nticitrullinated protein antibodies (ACPAs) are serological biomarkers associated with early, rapidly progressing rheumatoid arthritis (RA)",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27755123",
    "http://www.ncbi.nlm.nih.gov/pubmed/32079664",
    "http://www.ncbi.nlm.nih.gov/pubmed/25819755",
    "http://www.ncbi.nlm.nih.gov/pubmed/16188943",
    "http://www.ncbi.nlm.nih.gov/pubmed/22661643",
    "http://www.ncbi.nlm.nih.gov/pubmed/27696777",
    "http://www.ncbi.nlm.nih.gov/pubmed/23440041",
    "http://www.ncbi.nlm.nih.gov/pubmed/29290168",
    "http://www.ncbi.nlm.nih.gov/pubmed/30297575",
    "http://www.ncbi.nlm.nih.gov/pubmed/29200020",
    "http://www.ncbi.nlm.nih.gov/pubmed/25997035",
    "http://www.ncbi.nlm.nih.gov/pubmed/27348081",
    "http://www.ncbi.nlm.nih.gov/pubmed/31565241",
    "http://www.ncbi.nlm.nih.gov/pubmed/28826660",
    "http://www.ncbi.nlm.nih.gov/pubmed/25120260",
    "http://www.ncbi.nlm.nih.gov/pubmed/24429169",
    "http://www.ncbi.nlm.nih.gov/pubmed/26613769",
    "http://www.ncbi.nlm.nih.gov/pubmed/24206219",
    "http://www.ncbi.nlm.nih.gov/pubmed/18270852",
    "http://www.ncbi.nlm.nih.gov/pubmed/23716070"
  ],
  "snippets": [
    {
      "text": " Anticitrullinated Protein Antibodies in Patients With Long-standing Rheumatoid Arthritis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29200020",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The aim of this study was to evaluate the presence of autoantibodies to cyclic citrullinated synthetic peptides (ACPAs) in the sputum of patients with long-standing rheumatoid arthritis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29200020",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "nticitrullinated protein antibodies (ACPAs) are serological biomarkers associated with early, rapidly progressing rheumatoid arthritis (RA),",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29290168",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27755123",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "This article reviews recent literature on the origin and pathogenic role of anticitrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27755123",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES: To increase understanding of the aetiology and pathogenesis of rheumatoid arthritis (RA), genetic and environmental risk factors for RA subsets, defined by the presence or absence of different anticitrullinated protein/peptide antibodies (ACPAs) targeting citrullinated peptides from \u03b1-enolase, vimentin, fibrinogen and collagen type II, were investigated.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22661643",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Citrullinated proteins are observed in RA lung tissues; however, the association of specific anticitrullinated peptide antibodies (ACPA) with ILD in RA is unknown.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23716070",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23716070",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "This longitudinal study investigated (1) progression from CSA to clinically detectable arthritis and (2) associations of clinical factors, serological factors (among which are anticitrullinated peptide antibodies (ACPAs)) and MRI-detected subclinical inflammation with arthritis development.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26613769",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anticitrullinated peptide antibodies (ACPAs) are arguably the most likely candidate biomarker to screen for RA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32079664",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anticitrullinated protein antibodies (ACPAs) constitute a class of autoantibodies found in 60-70% of patients with rheumatoid arthritis (RA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24206219",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "BACKGROUND: Anticitrullinated protein antibodies (ACPAs) are serological biomarkers associated with early, rapidly progressing rheumatoid arthritis (RA), including more severe disease and joint damage.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29290168",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Antibodies targeting citrullinated proteins (ACPAs [anticitrullinated protein antibodies]) are commonly found in patients with rheumatoid arthritis (RA), strongly associate with distinct HLA-DR alleles, and predict a more aggressive disease course as compared with seronegative patients. Still, ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23440041",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES: Anticitrullinated protein/peptide antibodies (ACPA) have an excellent diagnostic performance for rheumatoid arthriti",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16188943",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anticitrullinated protein/peptide antibodies (ACPA) are highly specific for rheumatoid arthritis (RA). They",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18270852",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anticitrullinated protein antibodies (ACPAs) constitute a class of autoantibodies found in 60-70% of patients with rheumatoid arthritis (RA). The m",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24206219",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Background: Anti-citrullinated peptides antibodies (ACPA) are specific for rheumatoid arthritis and have been implicated in disease patho",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30297575",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anticitrullinated peptide/protein antibodies (ACPA), which are highly specific for rheumatoid arthritis (RA), may be found in some patients with other systemic autoimmune diseases. The c",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25997035",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Citrullinated proteins are observed in RA lung tissues; however, the association of specific anticitrullinated peptide antibodies (ACPA) with ILD in RA is unknown.M",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23716070",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anti-citrullinated protein/peptide antibodies (ACPAs) are detected in rheumatoid arthritis (RA) sera and because of their strict association with the disease are considered marker antibodies, probably endowed with pathogenic potential.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25120260",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES: Anti-citrullinated protein/peptide antibodies (ACPA) represent an important tool for the diagnosis of rheumatoid arthritis (RA) and the presence of multiple ACPA specificities is highly correlated with the evolution",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28826660",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVE: Anticitrullinated protein/peptide antibodies (ACPA) are implicated in rheumatoid arthritis (RA) pathogenesis and linked to the shared ep",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24429169",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anticitrullinated peptide/protein antibodies (ACPA), which are highly specific for rheumatoid arthritis (RA), may be found in some patients with other systemic autoimmune diseases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25997035",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Rheumatoid arthritis (RA) is an autoimmune connective tissue disease, associated with the presence of anti-citrullinated protein antibodies (ACPA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27348081",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Antibodies against citrullinated peptides are associated with clinical and radiological outcomes in patients with early rheumatoid arthritis: a prospective longitudinal inception cohort study.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31565241",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25997035",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Introduction: Anticitrullinated peptide antibody (ACPA) responses for 22 citrullinated peptides in patients with early rheumatoid arthritis (RA) were analysed and related to radiological and clinical outcome during the first 2 years in a prospective inc",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31565241",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Recent studies have revealed that periodontal disease (PD) is closely associated with RA and production of ACPA in RA.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25819755",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid Arthritis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27696777",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Anti-citrullinated peptide antibody (ACPA) is a highly specific autoantibody to rheumatoid arthritis (RA).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25819755",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "rheumatoid arthritis"
}